Literature DB >> 20443827

The roadmap to personalized medicine.

Scott A Waldman1, Andre Terzic.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 20443827      PMCID: PMC5439565          DOI: 10.1111/j.1752-8062.2008.00045.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


× No keyword cloud information.
  12 in total

1.  Targeted diagnostics and therapeutics for individualized patient management.

Authors:  Scott Waldman; Andre Terzic
Journal:  Biomark Med       Date:  2007-06       Impact factor: 2.851

2.  Clinical pharmacology: the science of therapeutics.

Authors:  S A Waldman; N B Christensen; J E Moore; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2007-01       Impact factor: 6.875

3.  The ethical implications of stratifying by race in pharmacogenomics.

Authors:  S S-J Lee
Journal:  Clin Pharmacol Ther       Date:  2007-01       Impact factor: 6.875

4.  Medical product development and regulatory science for the 21st century: the critical path vision and its impact on health care.

Authors:  S Buckman; S-M Huang; S Murphy
Journal:  Clin Pharmacol Ther       Date:  2007-02       Impact factor: 6.875

Review 5.  The prospects for "personalized medicine" in drug development and drug therapy.

Authors:  J Woodcock
Journal:  Clin Pharmacol Ther       Date:  2007-02       Impact factor: 6.875

6.  Breakthrough of the year. Human genetic variation.

Authors:  Elizabeth Pennisi
Journal:  Science       Date:  2007-12-21       Impact factor: 47.728

7.  A vision of individualized medicine in the context of global health.

Authors:  D A Cortese
Journal:  Clin Pharmacol Ther       Date:  2007-11       Impact factor: 6.875

8.  Molecular systems biology in drug development.

Authors:  P A Silver; J C Way
Journal:  Clin Pharmacol Ther       Date:  2007-07-18       Impact factor: 6.875

9.  Personalized medicine: elusive dream or imminent reality?

Authors:  L J Lesko
Journal:  Clin Pharmacol Ther       Date:  2007-06       Impact factor: 6.875

10.  Molecular medicine hones therapeutic arts to science.

Authors:  S A Waldman; M R Terzic; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2007-10       Impact factor: 6.875

View more
  3 in total

Review 1.  Widening the path to personalized medicine.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2011-10       Impact factor: 4.689

2.  Clinical and translational science: from bench-bedside to global village.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2010-10       Impact factor: 4.689

3.  The value proposition of molecular medicine.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2012-02-23       Impact factor: 4.689

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.